MOTS‑c: The Tiny Peptide Powering Your Cells Cellular Power
*A 16‑amino‑acid mitochondrial peptide that mimics exercise, improves energy production, and supports metabolic health.*
MOTS‑c (mitochondrial open reading frame of the 12S rRNA type‑c) is a naturally occurring 16‑amino‑acid peptide encoded by mitochondrial DNA. Dr. Jason Schuster explains that it enhances mitochondrial function, boosts ATP production, and can improve metabolic and cardiovascular health, essentially giving the body some of the same benefits that come from exercise.
MOTS‑c Defined
MOTS‑c is a mitochondrial peptide composed of 16 amino acids, making it shorter than many other therapeutic peptides. It is encoded by the 12S rRNA region of the mitochondrial genome, so it originates directly from mitochondrial DNA rather than nuclear DNA.
- 16 amino acids long
- Encoded by mitochondrial 12S rRNA
- Classified as a mitochondrial‑derived peptide
How It Works
According to Dr. Schuster, MOTS‑c improves communication between mitochondrial DNA and nuclear DNA, acting like an endocrine signal that modulates transcription of muscle metabolism, insulin response, and energy production. It raises intracellular mitochondrial NAD⁺ levels, which supports ATP synthesis, and it amplifies the Nrf2 anti‑inflammatory pathway.
- Enhances mito‑nuclear DNA signaling
- Increases mitochondrial NAD⁺ → more ATP
- Activates Nrf2, the key anti‑inflammatory pathway
Health Impacts
Dr. Schuster links MOTS‑c to several clinically relevant outcomes. By improving mitochondrial efficiency it can reduce inflammation, improve insulin resistance, support cardiovascular health, aid weight loss, and help counteract age‑related declines in energy.
- Decreases systemic inflammation
- Improves insulin sensitivity
- Supports cardiovascular function and reduces injury risk
- Enhances metabolism and assists weight management
- May mitigate age‑related decline in mitochondrial activity
Practical Use
The peptide is typically administered subcutaneously. Dr. Lee’s protocol, which Dr. Schuster references, uses 10 mg weekly on a rotational schedule (one‑to‑two months on, followed by an equal off period). Some clinicians reserve MOTS‑c for occasional use (once or twice a year) in specific protocols.
- 10 mg subcutaneous weekly (rotational schedule)
- Alternative protocol: occasional dosing 1–2 times per year
- Generally regarded as safe with minimal reported side effects
“MOTS‑c acts like an exercise‑mimetic peptide, giving you the benefits of a workout without having to move a muscle.”— Dr. Jason Schuster
Go deeper than the summary
Dr. Schuster's board-certified, accredited peptide therapy courses — the full research, dosing, and video breakdowns.